Company Overview of Fidelity Growth Partners Asia
Fidelity Growth Partners Asia is a venture capital and private equity firm specializing in early venture, mid venture, growth capital, and M&A investments. The firm primarily invests in technology, media, telecommunications, healthcare, education, logistics, financial services, medical treatment, and consumers. It seeks to invest in companies based in Asia, especially in Greater China. The firm typically invests between $5 million and $30 million and take minority stakes in companies. It prefers to take a board seat in its portfolio companies. Fidelity Growth Partners Asia is based in Central, Hong Kong with additional offices in Beijing, China and Shanghai, China. The firm operates as an op...
Two Pacific Place
No. 88 Queensway
Key Executives for Fidelity Growth Partners Asia
Senior Managing Director, Managing Partner, and Managing Partner, Asia
Managing Director, Partner, Chief Representative of Beijing, and Director
Compensation as of Fiscal Year 2015.
Fidelity Growth Partners Asia Key Developments
Fidelity Growth Partners Asia Presents at China Healthcare Investment Conference - Shanghai, Mar-31-2015 through Apr-02-2015
Mar 28 15
Fidelity Growth Partners Asia Presents at China Healthcare Investment Conference - Shanghai, Mar-31-2015 through Apr-02-2015. Venue: Shangri-La Pudong Hotel, 33 Fu Cheng Road, Pudong, Shanghai 200120, China. Presentation Date & Speakers: Apr-01-2015, Norman Chen, Venture Partner. Apr-02-2015, Norman Chen, Venture Partner, Rebecca Lin, Partner & Chief Representative. Mar-31-2015, Francine Fang, Venture Partner.
Fidelity Growth Parner Asia Presents at ChinaBio(R) Partnering Forum 2014, May-07-2014
May 1 14
Fidelity Growth Parner Asia Presents at ChinaBio(R) Partnering Forum 2014, May-07-2014 . Venue: Kempinski Hotel Suzhou, Suzhou, China.
Carlyle Group And Advent International Reportedly Mulls Stake In Laurus Labs
Feb 11 14
The Carlyle Group LP (NasdaqGS:CG) and Advent International Corporation are in discussions for a $150 million investment deal in Laurus Labs Private Limited, reported Economic Times citing at least two people familiar with the matter. Kohlberg Kravis Roberts & Co. (NYSE:KKR) and TA Associates Management, L.P. have also reported shown interest in Laurus Labs. Jefferies is running a fund-raising process for Laurus Labs. A person directly involved with the matter said, "The transaction may be a combination of fresh cash infusion and some secondary purchase of shares from existing investors." Jefferies is running a fund-raising process for Laurus Labs.
Similar Private Companies By Industry
Recent Private Companies Transactions